• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺病毒的中和作用:动力学、化学计量学及机制

Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms.

作者信息

Wohlfart C

机构信息

Department of Microbiology, University of Lund, Sweden.

出版信息

J Virol. 1988 Jul;62(7):2321-8. doi: 10.1128/JVI.62.7.2321-2328.1988.

DOI:10.1128/JVI.62.7.2321-2328.1988
PMID:3373570
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC253388/
Abstract

Kinetic curves for neutralization of adenovirus type 2 with anti-hexon serum revealed no lag periods even when the serum was highly diluted or when the temperature was lowered to 4 degrees C, thus indicating a single-hit mechanism. Multiplicity curves determined with anti-hexon serum displayed a linear correlation between the degree of neutralization and dilution of antiserum. Neutralization values experimentally obtained under steady-state conditions fully fitted a single-hit model based on Poisson calculations. Quantitation of the amount of 125I-labeled type-specific anti-hexon antibodies needed for full neutralization of adenovirus showed that 1.4 antibodies were attached per virion under such conditions. Virions already attached to HeLa cells at 4 degrees C were, to a large extent, neutralizable by anti-hexon serum, whereas anti-fiber and anti-penton base antisera were negative. It is suggested that adenovirus may be neutralized by two pathways: aggregation of the virions (extracellular neutralization) as performed by anti-fiber antibodies and blocking of virion entrance from the acidic endosomes into the cytoplasm (intracellular neutralization). The latter effect could be obtained by (i) covering of the penton bases, as performed by anti-penton base antibodies, thereby preventing interaction between the penton bases and the endosomal membrane, which results in trapping of virions within endosomes, and (ii) inhibition of the low-pH-induced conformational change of the viral capsid, which seems to occur in the endosomes and is necessary for proper exposure of the penton bases, as performed by anti-hexon antibodies.

摘要

用抗六邻体血清中和2型腺病毒的动力学曲线显示,即使血清被高度稀释或温度降至4℃,也没有延迟期,因此表明是单打击机制。用抗六邻体血清测定的多重复曲线显示中和程度与抗血清稀释度之间呈线性相关。在稳态条件下通过实验获得的中和值完全符合基于泊松计算的单打击模型。对完全中和腺病毒所需的125I标记的型特异性抗六邻体抗体量的定量显示,在这种条件下每个病毒粒子附着1.4个抗体。在4℃时已经附着在HeLa细胞上的病毒粒子在很大程度上可被抗六邻体血清中和,而抗纤维和抗五邻体基底抗血清则呈阴性。有人提出腺病毒可能通过两条途径被中和:病毒粒子的聚集(细胞外中和),如抗纤维抗体所执行的那样;以及阻止病毒粒子从酸性内体进入细胞质(细胞内中和)。后一种效应可以通过以下方式获得:(i)抗五邻体基底抗体覆盖五邻体基底,从而防止五邻体基底与内体膜之间的相互作用,这导致病毒粒子被困在内体中;(ii)抑制病毒衣壳的低pH诱导的构象变化,这种变化似乎发生在内体中,并且是五邻体基底正确暴露所必需的,如抗六邻体抗体所执行的那样。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ad8/253388/334c9ff36e5e/jvirol00086-0125-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ad8/253388/334c9ff36e5e/jvirol00086-0125-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ad8/253388/334c9ff36e5e/jvirol00086-0125-a.jpg

相似文献

1
Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms.腺病毒的中和作用:动力学、化学计量学及机制
J Virol. 1988 Jul;62(7):2321-8. doi: 10.1128/JVI.62.7.2321-2328.1988.
2
Interaction between HeLa cells and adenovirus type 2 virions neutralized by different antisera.人宫颈癌HeLa细胞与被不同抗血清中和的2型腺病毒颗粒之间的相互作用。
J Virol. 1985 Dec;56(3):896-903. doi: 10.1128/JVI.56.3.896-903.1985.
3
Antibodies with specificities against a dispase-produced 15-kilodalton hexon fragment neutralize adenovirus type 2 infectivity.对分散酶产生的15千道尔顿六邻体片段具有特异性的抗体可中和2型腺病毒的感染性。
J Virol. 1990 Sep;64(9):4217-25. doi: 10.1128/JVI.64.9.4217-4225.1990.
4
Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.人类对腺病毒重组衣壳蛋白的免疫反应:抗纤维抗体和抗五聚体基底抗体对中和活性具有协同作用。
J Virol. 1998 Mar;72(3):2388-97. doi: 10.1128/JVI.72.3.2388-2397.1998.
5
Antipeptide antisera define neutralizing epitopes on the adenovirus hexon.抗肽抗血清可确定腺病毒六邻体上的中和表位。
J Gen Virol. 1992 Jun;73 ( Pt 6):1429-35. doi: 10.1099/0022-1317-73-6-1429.
6
Identification of adenovirus (ad) penton base neutralizing epitopes by use of sera from patients who had received conditionally replicative ad (addl1520) for treatment of liver tumors.通过使用接受条件性复制腺病毒(ad dl1520)治疗肝肿瘤患者的血清来鉴定腺病毒五聚体基底中和表位。
J Virol. 2003 Oct;77(19):10366-75. doi: 10.1128/jvi.77.19.10366-10375.2003.
7
[Antibodies to hexon in the immunological inactivation of adenoviruses].[腺病毒免疫灭活中六邻体抗体的作用]
Mikrobiol Zh (1978). 1981 Mar-Apr;43(2):212-8.
8
Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies.用于生产病毒型特异性抗体的小尺寸重组腺病毒六邻体蛋白片段。
Virol J. 2017 Aug 18;14(1):158. doi: 10.1186/s12985-017-0822-5.
9
Characteristics of neutralizing antibodies to adenovirus capsid proteins in human and animal sera.中和抗体对人及动物血清中腺病毒衣壳蛋白的特性研究。
Virology. 2013 Mar 15;437(2):118-23. doi: 10.1016/j.virol.2012.12.014. Epub 2013 Jan 23.
10
Penton base induces better protective immune responses than fiber and hexon as a subunit vaccine candidate against adenoviruses.戊二醛基能比纤维蛋白和六邻体作为腺病毒亚单位疫苗候选物诱导更好的保护性免疫应答。
Vaccine. 2018 Jul 5;36(29):4287-4297. doi: 10.1016/j.vaccine.2018.05.118. Epub 2018 Jun 7.

引用本文的文献

1
Lactoferricin enables adenovirus infection of human skeletal muscle cells.乳铁传递蛋白促成腺病毒对人骨骼肌细胞的感染。
Npj Viruses. 2025 Aug 19;3(1):62. doi: 10.1038/s44298-025-00144-7.
2
Coordinated antiviral immune response in a patient with myeloma and systemic adenovirus infection post-BCMA CAR T cells.一名多发性骨髓瘤患者在接受靶向B细胞成熟抗原(BCMA)的嵌合抗原受体(CAR)T细胞治疗后发生系统性腺病毒感染时的协调抗病毒免疫反应
Blood Adv. 2024 Nov 26;8(22):5880-5884. doi: 10.1182/bloodadvances.2024012762.
3
The Immune System-A Double-Edged Sword for Adenovirus-Based Therapies.

本文引用的文献

1
Neutralization of viral infectivity: characterization of the virus-antibody complex, including association, dissociation, and host-cell interaction.
Ann N Y Acad Sci. 1960 Jan 13;83:515-27. doi: 10.1111/j.1749-6632.1960.tb40925.x.
2
THE INTERACTION OF NEWCASTLE DISEASE VIRUS AND NEUTRALIZING ANTIBODY.新城疫病毒与中和抗体的相互作用
Virology. 1965 Jan;25:38-47. doi: 10.1016/0042-6822(65)90249-7.
3
IMMUNIZATION OF VOLUNTEERS WITH SOLUBLE ANTIGENS OF ADENOVIRUS TYPE 1.用1型腺病毒可溶性抗原对志愿者进行免疫接种。
免疫系统——腺病毒疗法的双刃剑。
Viruses. 2024 Jun 17;16(6):973. doi: 10.3390/v16060973.
4
Neutralizing monoclonal antibodies protect against human adenovirus type 55 infection in transgenic mice and tree shrews.中和单克隆抗体可预防转基因小鼠和树鼩感染人 55 型腺病毒。
Emerg Microbes Infect. 2024 Dec;13(1):2307513. doi: 10.1080/22221751.2024.2307513. Epub 2024 Feb 1.
5
Gene Therapy in Organ Transplantation: Considerations and Clinical Translation.器官移植中的基因治疗:考虑因素与临床转化。
Hum Gene Ther. 2024 Apr;35(7-8):284-297. doi: 10.1089/hum.2023.193. Epub 2024 Jan 30.
6
Knob domain of Fiber 2 protein provides full protection against fowl adenovirus serotype 4.纤维 2 蛋白的 knob 结构域提供针对禽腺病毒血清型 4 的完全保护。
Virus Res. 2023 Jun;330:199113. doi: 10.1016/j.virusres.2023.199113. Epub 2023 Apr 12.
7
Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy.腺病毒载体治疗中预先存在的载体免疫和固有免疫反应激活的意义。
Viruses. 2022 Dec 6;14(12):2727. doi: 10.3390/v14122727.
8
Adenovirus Type 6: Subtle Structural Distinctions from Adenovirus Type 5 Result in Essential Differences in Properties and Perspectives for Gene Therapy.6型腺病毒:与5型腺病毒在结构上的细微差异导致其在基因治疗的特性和前景方面存在本质区别。
Pharmaceutics. 2021 Oct 8;13(10):1641. doi: 10.3390/pharmaceutics13101641.
9
Fractionating a COVID-19 Ad5-vectored vaccine improves virus-specific immunity.将 COVID-19 Ad5 载体疫苗进行分段可提高病毒特异性免疫。
Sci Immunol. 2021 Dec 3;6(66):eabi8635. doi: 10.1126/sciimmunol.abi8635.
10
Adenovirus Vectors: Excellent Tools for Vaccine Development.腺病毒载体:疫苗开发的优秀工具。
Immune Netw. 2021 Feb 15;21(1):e6. doi: 10.4110/in.2021.21.e6. eCollection 2021 Feb.
Proc Soc Exp Biol Med. 1964 Oct;117:186-90. doi: 10.3181/00379727-117-29531.
4
PRODUCTION OF SPECIFIC NEUTRALIZING ANTIBODY WITH SOLUBLE ANTIGENS OF TYPE 5 ADENOVIRUS.用5型腺病毒可溶性抗原产生特异性中和抗体
Proc Soc Exp Biol Med. 1963 Oct;114:37-42. doi: 10.3181/00379727-114-28579.
5
THE INTERACTION BETWEEN VIRUS AND ANTIBODY. I. KINETIC STUDIES.病毒与抗体之间的相互作用。I. 动力学研究。
Virology. 1963 Sep;21:61-75. doi: 10.1016/0042-6822(63)90305-2.
6
Studies on the interactions of adenovirus, antibody, and host cells in vitro.
Virology. 1962 Nov;18:448-56. doi: 10.1016/0042-6822(62)90035-1.
7
On the mechanism of Newcastle disease virus neutralization by immune serum.
Virology. 1957 Feb;3(1):84-95. doi: 10.1016/0042-6822(57)90025-9.
8
A study of the basic aspects of neutralization of two animal viruses, western equine encephalitis virus and poliomyelitis virus.一项关于两种动物病毒——西部马脑炎病毒和脊髓灰质炎病毒——中和作用基本方面的研究。
Virology. 1956 Apr;2(2):162-205. doi: 10.1016/0042-6822(56)90017-4.
9
Virus-receptor interaction in the adenovirus system I. Identification of virion attachment proteins of the HeLa cell plasma membrane.腺病毒系统中的病毒-受体相互作用I. 鉴定HeLa细胞质膜的病毒体附着蛋白。
J Virol. 1981 Apr;38(1):70-81. doi: 10.1128/JVI.38.1.70-81.1981.
10
Studies on the mechanism of neutralization of influenza virus by antibody: evidence that neutralizing antibody (anti-haemagglutinin) inactivates influenza virus in vivo by inhibiting virion transcriptase activity.抗体中和流感病毒机制的研究:中和抗体(抗血凝素)通过抑制病毒粒子转录酶活性在体内使流感病毒失活的证据。
J Gen Virol. 1982 Feb;58(Pt 2):373-86. doi: 10.1099/0022-1317-58-2-373.